Fujirebio Diagnostics’ CYFRA 21-1 EIA Assay Earns 510(k) Clearance
This is the first biomarker assay kit to be cleared by the FDA for use in the management of patients with lung cancer.
Read MoreSearch Results for: lung cancer
Duncan Whitney, Ph.D. Joins Allegro Diagnostics as Vice President, R & D
Posted by Clinical Lab Products | Apr 19, 2010 | Cancer, Miscellaneous |
Allegro Diagnostics, a leader in the field of molecular diagnostics for lung cancer, has announced that Duncan Whitney, Ph.D., has joined the company as Vice President, Research & Development.
Read MoreAlmac Diagnostics and Eli Lilly Partner on Companion Diagnostic Development
Posted by Clinical Lab Products | Sep 22, 2009 | Cancer, Miscellaneous |
Almac and Lilly UK have entered into a partnership to develop a companion diagnostic for ALIMTA, with cisplatin, as a combination therapy for non-squamous non-small cell lung cancer.
Read MoreDxS and AstraZeneca to Provide Companion Diagnostic for IRESSA
Posted by Clinical Lab Products | Aug 3, 2009 | Cancer, Miscellaneous |
DxS Ltd announces it is working closely with AstraZeneca to make available a companion diagnostic for use with IRESSA (gefitinib), AstraZenecas treatment for non small cell lung cancer (NSCLC).
Read MoreNIH Funds Development of Novel Standardized Genetic-Profiling Test
Posted by Clinical Lab Products | Jul 3, 2008 | Cancer, Miscellaneous |
BioTrove Inc, Woburn, Mass, and Gene Express Inc, Toledo, Ohio, have received a two-year National Institutes of Health grant for their proposed novel research of genetic biomarkers for lung cancer.
Read More